Skip to main content
. Author manuscript; available in PMC: 2015 Feb 23.
Published in final edited form as: Ann Surg Oncol. 2013 Aug 23;20(13):4103–4112. doi: 10.1245/s10434-013-3194-0

TABLE 5.

Predictors of locoregional recurrence (LRR) in patients with ductal carcinoma-in situ treated with mastectomy (n = 810)

Characteristics Patients with LRR, n (%) Patients without LRR, n (%) p value
All patients 8 (1.0) 802 (99.0)
Race
 White 7 (87.5) 593 (74.0)
 African American 1 (12.5) 84 (10.5)
 Hispanic 0 (0) 66 (8.2)
 Asian/Pacific Islander 0 (0) 46 (5.7)
 Other 0 (0) 13 (1.6) 0.831
Age, years, median (range) 53 (20–88) 47.5 (41–62) 0.363
Menopausal statusa
 Premenopausal 5 (62.5) 274 (34.2)
 Postmenopausal 3 (37.5) 526 (65.8) 0.096
Bilateral breast cancer at diagnosis
 Yes 1 (12.5) 99 (12.5)
 No 7 (87.5) 703 (87.6) 0.997
Initial presentationb
 Clinical 1 (12.5) 187 (23.5)
 Radiological 7 (87.5) 611 (76.5) 0.464
Largest recorded mammographic dimension, cm, median (range)c 2.5 (0.7–14) 3.5 (0.3–20) 0.816
Skin-sparing mastectomy
 Yes 7 (87.5) 462 (57.5)
 No 1 (12.5) 340 (42.5) 0.088
Immediate breast reconstruction
 Yes 7 (87.5) 527 (65.8)
 No 1 (12.5) 275 (34.3) 0.196
Contralateral prophylactic mastectomy
 Yes 1 (12.5) 132 (16.4)
 No 7 (87.5) 670 (83.6) 0.765
Largest recorded pathologic lesion size, cm, median (range)d 1.2 (0.5–8.0) 2.2 (0.02–19) 0.659
Nuclear gradee
 I or II 2 (25.0) 349 (44.1)
 III 6 (75.0) 442 (55.9) 0.278
Margin status
 ≤1 mm 3 (37.5) 56 (7.0)
 1.1–2.9 mm 1 (12.5) 34 (4.2)
 ≥3 mm 4 (50.0) 712 (88.8) 0.002
Multicentricf
 Yes 5 (100.0) 242 (38.4)
 No 0 (0) 389 (61.7) 0.005
Multifocalg
 Yes 5 (100.0) 233 (38.2)
 No 0 (0) 377 (61.8) 0.005
Comedoh
 Yes 2 (25.0) 250 (32.6)
 No 6 (75.0) 517 (67.4) 0.648
Necrosis
 Yes 6 (75.0) 378 (47.1)
 No 2 (25.0) 424 (52.9) 0.115
a

Two patients were perimenopausal

b

Not available for four patients

c

Not available for 423 patients

d

Not available for 181 patients

e

Not available for 11 patients

f

Not available for 174 patients

g

Not available for 195 patients

h

Not available for 35 patients